Antimicrobial properties of distinctin in an experimental model of MRSA-infected wounds

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 11, 2012, Pages 3047-3055

  Simonetti, O ^a,d   Cirioni, O ^a   Ghiselli, R ^a   Goteri, G ^a   Orlando, F ^a   Monfregola, L ^b   De Luca, S ^b   Zizzi, A ^a   Silvestri, C ^a   Veglia, G ^c   Giacometti, A ^a   Guerrieri, M ^a   Offidani, A ^a   Scaloni, A ^b  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF MINNESOTA   (United States)

^d OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CD31 ANTIGEN; DISTINCTIN; TEICOPLANIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG POTENTIATION; GRANULATION TISSUE; GROWTH INHIBITION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROVASCULATURE; MINIMUM INHIBITORY CONCENTRATION; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WOUND INFECTION;

ADMINISTRATION, TOPICAL; AMPHIBIAN PROTEINS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL LOAD; DISEASE MODELS, ANIMAL; HISTOCYTOCHEMISTRY; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MICE; MICE, INBRED BALB C; SKIN; STAPHYLOCOCCAL SKIN INFECTIONS; TEICOPLANIN; TREATMENT OUTCOME; WOUND INFECTION;

EID: 84868000101     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1663-1     Document Type: Article

References (45)

1. Saleh K, Sonesson A, Persson B, Riesbeck K, Schmidtchen A (2011) A descriptive study of bacterial load of full-thickness surgical wounds in dermatologic surgery. Dermatol Surg 37(7):1014-1022
2. Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111:1265-1273
3. Bone RC (1994) Gram-positive organisms and sepsis. Arch Intern Med 154:26-34
4. Howell-Jones RS, Wilson MJ, Hill KE, Howard AJ, Price PE, Thomas DW (2005) A review of the microbiology, antibiotic usage and resistance in chronic skin wounds. J Antimicrob Chemother 55:143-149
5. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520-532
6. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24(12):1551-1557
7. Pukala TL, Bowie JH, Maselli VM, Musgrave IF, Tyler MJ (2006) Host-defence peptides from the glandular secretions of amphibians: structure and activity. Nat Prod Rep 23(3):368-393
8. Rinaldi AC (2002) Antimicrobial peptides from amphibian skin: an expanding scenario. Curr Opin Chem Biol 6(6):799-804
9. Lipsky BA, Holroyd KJ, Zasloff M (2008) Topical versus systemic antimicrobial therapy for treating mildly infected diabetic foot ulcers: a randomized, controlled, double-blinded, multicenter trial of pexiganan cream. Clin Infect Dis 47:1537-1545
10. Batista CV, Scaloni A, Rigden DJ, Silva LR, Rodrigues Romero A, Dukor R, Sebben A, Talamo F, Bloch C (2001) A novel heterodimeric antimicrobial peptide from the tree-frog Phyllomedusa distincta. FEBS Lett 494(1-2):85-89
11. Cirioni O, Ghiselli R, Orlando F, Silvestri C, De Luca S, Salzano AM, Mocchegiani F, Saba V, Scalise G, Scaloni A, Giacometti A (2008) Efficacy of the amphibian peptide distinctin in a neutropenic mouse model of staphylococcal sepsis. Crit Care Med 36(9):2629-2633
12. Dalla Serra M, Cirioni O, Vitale RM, Renzone G, Coraiola M, Giacometti A, Potrich C, Baroni E, Guella G, Sanseverino M, De Luca S, Scalise G, Amodeo P, Scaloni A (2008) Structural features of distinctin affecting peptide biological and biochemical properties. Biochemistry 47(30):7888-7899
13. Lee IH, Lee YS, Kim CH, Kim CR, Hong T, Menzel L, Boo LM, Pohl J, Sherman MA, Waring A, Lehrer RI (2001) Dicynthaurin: an antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. Biochim Biophys Acta 1527:141-148
14. Jang WS, Kim KN, Lee YS, Nam MH, Lee IH (2002) Halocidin: a new antimicrobial peptide from hemocytes of the solitary tunicate, Halocynthia aurantium. FEBS Lett 521:81-86
15. Yomogida S, Nagaoka I, Yamashita T (1996) Purification of the 11- and 5-kDa antibacterial polypeptides from guinea pig neutrophils. Arch Biochem Biophys 328:219-226
16. Scocchi M, Zelezetsky I, Benincasa M, Gennaro R, Mazzoli A, Tossi A (2005) Structural aspects and biological properties of the cathelicidin PMAP-36. FEBS J 272:4398-4406
17. Raimondo D, Andreotti G, Saint N, Amodeo P, Renzone G, Sanseverino M, Zocchi I, Molle G, Motta A, Scaloni A (2005) A folding-dependent mechanism of antimicrobial peptide resistance to degradation unveiled by solution structure of distinctin. Proc Natl Acad Sci USA 102(18):6309-6314
18. Jang WS, Kim CH, Kim KN, Park SY, Lee JH, Son SM, Lee IH (2003) Biological activities of synthetic analogs of halocidin, an antimicrobial peptide from the tunicate Halocynthia aurantium. Antimicrob Agents Chemother 47:2481-2486
19. Okuda D, Yomogida S, Tamura H, Nagaoka I (2006) Determination of the antibacterial and lipopolysaccharide-neutralizing regions of guinea pig neutrophil cathelicidin peptide CAP11. Antimicrob Agents Chemother 50:2602-2607
20. Jang WS, Lee SC, Lee YS, Shin YP, Shin KH, Sung BH, Kim BS, Lee SH, Lee IH (2007) Antimicrobial effect of halocidin-derived peptide in a mouse model of Listeria infection. Antimicrob Agents Chemother 51(11):4148-4156
21. Shin YP, Park HJ, Shin SH, Lee YS, Park S, Jo S, Lee YH, Lee IH (2010) Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases. Antimicrob Agents Chemother 54(7):2855-2866
22. Lauer G, Sollberg S, Cole M, Flamme I, Stürzebecher J, Mann K, Krieg T, Eming SA (2000) Expression and proteolysis of vascular endothelial growth factor is increased in chronic wounds. J Invest Dermatol 115:12-18
23. Byrne AM, Bouchier-Hayes DJ, Harmey JH (2005) Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 9:777-794
24. Cianfarani F, Tommasi R, Failla CM, Viviano MT, Annessi G, Papi M, Zambruno G, Odorisio T (2006) Granulocyte/macrophage colony-stimulating factor treatment of human chronic ulcers promotes angiogenesis associated with de novo vascular endothelial growth factor transcription in the ulcer bed. Br J Dermatol 154:34-41
25. Frantz S, Vincent KA, Feron O, Kelly RA (2005) Innate immunity and angiogenesis. Circ Res 96:15-26
26. Asai J, Takenaka H, Katoh N, Kishimoto S (2006) Dibutyryl cAMP influences endothelial progenitor cell recruitment during wound neovascularization. J Invest Dermatol 126:1159-1167
27. Shinzawa H, Takeda A, Sone Y, Murashita K, Uchinuma E (2007) Wound healing process of a full-thickness skin wound model in rats. Int Surg 92:63-72
28. Niyonsaba F, Ushio H, Nakano N, Ng W, Sayama K, Hashimoto K, Nagaoka I, Okumura K, Ogawa H (2007) Antimicrobial peptides human beta-defensins stimulate epidermal keratinocyte migration, proliferation and production of proinflammatory cytokines and chemokines. J Invest Dermatol 127:594-604
29. Pace JL, Yang G (2006) Glycopeptides: update on an old successful antibiotic class. Biochem Pharmacol 71:968-980
30. Clinical and Laboratory Standards Institute (CLSI) (2003) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard M7-A6. CLSI, Villanova, PA
31. Eliopoulos GM, Moellering RC Jr (1996) Antimicrobial combinations. In: Lorian V (ed) Antibiotics in laboratory medicine, 4th edn. Williams & Wilkins, Baltimore, pp 330-393
32. Simonetti O, Cirioni O, Goteri G, Ghiselli R, Kamysz W, Kamysz E, Silvestri C, Orlando F, Barucca C, Scalise A, Saba V, Scalise G, Giacometti A, Offidani A (2008) Temporin A is effective in MRSA-infected wounds through bactericidal activity and acceleration of wound repair in a murine model. Peptides 29(4):520-528
33. Fung HB, Chang JY, Kuczynski SA (2003) Practical guide to the treatment of complicated skin and soft tissue infections. Drugs 63:1459-1480
34. Bergmann S, Hammerschmidt S (2007) Fibrinolysis and host response in bacterial infections. Thromb Haemost 98(3):512-520
35. [No authors listed] (1993) Proteolytic enzymes in coagulation, fibrinolysis, and complement activation. Part A. Mammalian blood coagulation factors and inhibitors. Methods Enzymol 222:1-559
36. Yeaman MR, Yount NY (2003) Mechanisms of antimicrobial peptide action and resistance. Pharmacol Rev 55(1):27-55
37. Vaara M, Porro M (1996) Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Antimicrob Agents Chemother 40:1801-1805
38. Mangoni ML, Rinaldi AC, Di Giulio A, Mignogna G, Bozzi A, Barra D, Simmaco M (2000) Structure-function relationships of temporins, small antimicrobial peptides from amphibian skin. Eur J Biochem 267:1447-1454
39. Rinaldi AC, Mangoni ML, Rufo A, Luzi C, Barra D, Zhao H, Kinnunen PK, Bozzi A, Di Giulio A, Simmaco M (2002) Temporin L: antimicrobial, haemolytic and cytotoxic activities, and effects on membrane permeabilization in lipid vesicles. Biochem J 368:91-100
40. Resende JM, Moraes CM, Munhoz VH, Aisenbrey C, Verly RM, Bertani P, Cesar A, Piló-Veloso D, Bechinger B (2009) Membrane structure and conformational changes of the antibiotic heterodimeric peptide distinctin by solid-state NMR spectroscopy. Proc Natl Acad Sci U S A 106(39):16639-16644
41. Martin P (1997) Wound healingaiming for perfect skin regeneration. Science 276:75-81
42. Santoro MM, Gaudino G (2005) Cellular and molecular facets of keratinocyte reepithelization during wound healing. Exp Cell Res 304:274-286
43. Werner S, Krieg T, Smola H (2007) Keratinocyte-fibroblast interactions in wound healing. J Invest Dermatol 127:998-1008
44. Naldini A, Carraro F (2005) Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy 4:3-8
45. Ho QT, Kuo CJ (2007) Vascular endothelial growth factor: biology and therapeutic applications. Int J Biochem Cell Biol 39(7-8):1349-1357